PSG RxWire
Advancing and protecting our clients' interests in the pharmacy benefit marketplace for more than 20 years.
FDA APPROVALS

Farydak for treatment of multiple myeloma



2015 PBMI Conference
SUMMARY OF TOP ARTICLES - FEBRUARY 26, 2015

Why Are Generic Drugs Getting More Expensive?
Drug Channels - February 20, 2015
Over the past two years, the pharmacy industry has seen unprecedented increases in the prices of generic drugs, causing unexpected cost increases for payers and consumers. The sudden increase in generic drug prices also spurred an investigation by the United States Congress.

Study Compares Drugs for Diabetes-Linked Eye Disease
HealthDay News - February 18, 2015
A vision-robbing condition called diabetic macular edema can strike people with diabetes.

Newer Blood Thinner Beats Heparin for Certain Heart Attacks
HealthDay News - February 17, 2015
A blood thinner already used to treat dangerous blood clots in the limbs and lungs appears to be safer in treating certain heart attacks than the more powerful blood thinner that's traditionally used, a new Swedish study has found.

Compounding pharmacies chafe at FDA's disciplinary actions
BioPharma Dive - February 23, 2015
The FDA has been cracking down on compounding pharmacies in the wake of a highly publicized meningitis outbreak linked to tainted steroids from a compounder.

CMS announces special enrollment period for tax season
Managed Healthcare Executive - February 20, 2015
The Centers for Medicare and Medicaid Services (CMS) announced on February 20 a special enrollment period (SEP) for individuals and families who did not have health coverage in 2014 and are subject to the fee or “shared responsibility payment” on their 2014 taxes in states which use the federally-facilitated marketplaces (FFM).

Seasonal Flu Vaccine May Protect Against Deadly Bird Flu
HealthDay News - February 17, 2015
Seasonal fluvaccines trigger immune system protectionagainst the deadly H7N9 bird flu virus, a new study reveals.

Diabetes drug could protect against low blood sugar
ScienceDaily - February 20, 2015
DPP-4 inhibitors are a group of drugs used to treat type 2 diabetes that lower high blood sugar levels by stimulating insulin production in the body. Researchers have now discovered that DPP-4 inhibitors are also effective against low blood sugar levels. The study was carried out on mice.

After Lobbying Push, Drugmaker Resubmits Women's Sex Pill
Associated Press - February 18, 2015
The makers of a twice-rejected pill designed to boost sexual desire in women are hoping a yearlong lobbying push by politicians, women's groups and consumer advocates will move their much-debated drug onto the market.

ADHD medication revenue is up: report
New York Daily News - February 19, 2015
The ADHD Medication Manufacturing Industry, a trade group, is expecting 13% growth in revenue this year, according to the latest numbers. By 2020, ADHD meds are expected to be a $17.5 billion industry.

Generic Eye Drops for Glaucoma Encourage Greater Use
HealthDay News - February 19, 2015
Glaucoma patients are more likely to take medications to treat their eye disease if they're prescribed generic drugs, a new study finds.

Drug use differs for exchange members
Managed Healthcare Executive - February 9, 2015
Two recent studies show that members who obtain health insurance through state or federal insurance exchanges use more specialty and generic drugs than their counterparts in commercial plans.

Competition Among Physicians, Retail Clinics Drive Higher Antibiotic Prescribing Rate
Johns Hopkins Medicine - Frebruary 23, 2015
Competition among doctors’ offices, urgent care centers and retail medical clinics in wealthy areas of the U.S. often leads to an increase in the number of antibiotic prescriptions written per person, a team led by Johns Hopkins researchers has found.


Contact,

Jan Tankersley
Senior Vice President, Marketing & Sales
Pharmaceutical Strategies Group (PSG)
Office: 972-943-7141
Email: JTankersley@PSGConsults.com

PSGNewsletter@PSGConsults.com
www.PSGConsults.com